Scott Kopetz
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Scott Kopetz
Jun 8, 2024, 11:07 |
Insight
Novel targeted cancer therapies demonstrate activity and safety in metastatic solid tumors
MD Anderson researchers share preliminary clinical data of an antibody-drug conjugate for metastatic colorectal cancer…
May 28, 2024, 14:22 |
Insight
Combination therapy significantly improves outcomes for patients with metastatic colorectal cancer - UCLA Health
Combining immune-targeted therapy with chemotherapy improves both progression-free survival and overall survival when compared to…
May 19, 2024, 10:23 |
Blog
Anne Tsao: MD Anderson Cancer Center Ascending SFC Networking Event and Fireside Chat on Sponsorship
Anne Tsao, Vice-President of Academic Affairs at MD Anderson Cancer Center, shared on LinkedIn: "Thrilled…
Apr 1, 2024, 15:26 |
Societies
The American Association for Cancer Research congratulates the 2024 AACR Scientific Achievement Award and Lectureship recipients
The American Association for Cancer Research recently shared on their X/Twitter page: "We congratulate all…
Feb 29, 2024, 19:06 |
Insight
Michael Sapienza: The largest-ever philanthropic investment in CRC research
Michael Sapienza, CEO of Colorectal Cancer Alliance, shared on LinkedIn: "I’m writing with exciting news…
Nov 7, 2023, 18:58 |
Blog
Pashtoon Kasi: Want to learn more about ctDNA and some of the challenges beyond the assay?
Pashtoon Kasi, Oncologist and researcher at Weill Cornell Medicine and NewYork-Presbyterian Hospital, shared a post on…
Jul 30, 2023, 18:33 |
Career
Congratulations Scott Kopetz our new Associate Vice President for Translational Integration at MD Anderson Cancer Center - Anirban Maitra
Congratulations Scott Kopetz our new Associate Vice President for Translational Integration at MD Anderson Cancer…
All:
7
Posts:
1 - 10
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
We mourn the loss of our Ivy Elkins
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Rob Winn: Honored to receive the ASCO Allen Lichter Visionary Leader Award
Yardena Samuels: An absolute honor to be elected as the next EACR president
Facebook
RSS Feed
Twitter
Linkedin
Youtube